RT @hausmannMD: Interesting withdrawal study of tofacitinib in children with JIA showed that drug was better than placebo at preventing dis…
Tweet Content
Interesting withdrawal study of tofacitinib in children with JIA showed that drug was better than placebo at preventing disease flares. #pedirheum #ACR19 @RheumNow https://t.co/lHWNJGmmtF
Show on Archive Page
On
Display in Search Results
On